CIK 0001395064 · Large accelerated filer
TAKEDA PHARMACEUTICAL CO LTD
Sign in to watch- Ticker
- TKPHF
- Exchange
- NYSE, OTC
- Industry
- Pharmaceutical Preparations
- Entity type
- other
- Phone
- 81332782111
- Business address
- 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, Japan, 103-8668
Securities
- TAK Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) NYSE
- TKPHF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,523,173
- in 6 filings, $2.5M under 10b5-1 plans
Net −$5,523,173. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Plump Andrew Stewart −$2.5M President, R&D sold 48% of stake
- Platford Giles Richard −$1.2M President, IBU sold 17% of stake
- Bitetti Teresa Marie −$974K President, OBU sold 18% of stake
- Duprey Lauren Rusckowski −$640K Chief Transformation Officer sold 15% of stake
- Greenway Nicola Deidre Petal −$235K Chief Human Resources Officer sold 24% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Stoffels Paulus Director | Grant or award · Tax Obligation Award | +1,307 | 1,307 | ||
| 2026-07-01 | Kimura Koichiro Director | Grant or award | +1,800 | 1,800 | ||
| 2026-07-01 | Kimura Koichiro Director | Grant or award · Tax Obligation Award | +1,937 | 1,937 | ||
| 2026-07-01 | Tsusaka Miki Director | Grant or award | +1,800 | 8,200 | ||
| 2026-07-01 | Tsusaka Miki Director | Grant or award · Tax Obligation Award | +1,937 | 1,937 | ||
| 2026-07-01 | Miyabashira Asuka President, Japan Pharma B.U. | Grant or award | +1,500 | 4,500 | ||
| 2026-07-01 | Miyabashira Asuka President, Japan Pharma B.U. | Grant or award · Tax Obligation Award | +664 | 1,392 | ||
| 2026-07-01 | Miyabashira Asuka President, Japan Pharma B.U. | Grant or award · Tax Obligation Award | +664 | 1,174 | ||
| 2026-07-01 | Miyabashira Asuka President, Japan Pharma B.U. | Grant or award · Tax Obligation Award | +666 | 666 | ||
| 2026-07-01 | Furuta Milano Chief Financial Officer | Grant or award | +12,300 | 70,200 | ||
| 2026-07-01 | Furuta Milano Chief Financial Officer | Grant or award · Tax Obligation Award | +4,288 | 11,741 | ||
| 2026-07-01 | Furuta Milano Chief Financial Officer | Grant or award · Tax Obligation Award | +4,288 | 8,482 | ||
| 2026-07-01 | Furuta Milano Chief Financial Officer | Grant or award · Tax Obligation Award | +4,288 | 4,288 | ||
| 2026-07-01 | Platford Giles Richard President, IBU | Grant or award | +49,558 | 346,921 | ||
| 2026-07-01 | Smoter Jennifer Marie Chief Comm. & Gov. Officer | Grant or award | +18,808 | 18,808 | ||
| 2026-07-01 | Ibrahim Ramy Riad Ahmed President, PDT BU | Grant or award | +25,078 | 109,865 | ||
| 2026-07-01 | Greenway Nicola Deidre Petal Chief Human Resources Officer | Grant or award | +22,570 | 94,406 | ||
| 2026-07-01 | Farajallah Awny Samaan Botros Chief Medical Officer | Grant or award | +17,554 | 130,183 | ||
| 2026-07-01 | Furney Natalie Anne Marie Global General Counsel | Grant or award | +43,886 | 235,166 | ||
| 2026-07-01 | Pacheco Rhonda Janice President, U.S. Business Unit | Grant or award | +50,156 | 199,408 |
Page 3 of 5 · 83 trades